CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

FDA Grants 510(k) Clearance to New Spinal Implant

Published: Fri, 17 Aug 2018 09:52:25 EDT
The Foundation 3D anterior lumbar interbody cage implant uses CoreLink's proprietary mimetic metal technology, which mimics key characteristics of natural bone.
FDA Approvals

WGA Speeds Diagnosis of Devastating Seizure Disorder in Kids

Published: Fri, 17 Aug 2018 09:37:19 EDT
Whole-genome analysis looks more clinically and economically feasible for diagnosing newborns with a rare, but devastating, epilepsy syndrome, new research shows.
Medscape Medical News

Weight Gain Doesn't Diminish Benefits of Giving Up Smoking

Published: Fri, 17 Aug 2018 08:48:40 EDT
Risk for type 2 diabetes rises temporarily for people who gain weight when they quit smoking, but cardiovascular benefit stays steady regardless.
Medscape Medical News
Displaying results 16-18 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Batycky exits Acorda to head up new biotech

Published: Tue, 14 Aug 2018 13:05:00 +0000
Acorda Therapeutics’ chief technology officer, Rick Batycky, Ph.D., is leaving the company next week after four years in the role to head up his own operation.

Realm tanks again as second drug fails phase 2

Published: Tue, 14 Aug 2018 08:55:00 +0000
Realm Therapeutics has reported its second midphase flop of the year. The setback threatens to wipe out Realm’s clinical-phase pipeline, leaving the immunology player with just a preclinical acne asset that features the same active ingredient as the failed programs.

Bioverativ executive Rogerio Vivaldi to helm cell therapy producer Sigilon

Published: Mon, 13 Aug 2018 18:47:47 +0000
Sigilon Therapeutics is bringing on Bioverativ’s chief global therapeutic operations officer, Rogerio Vivaldi, M.D., to serve as its CEO. The change comes as Sigilon plans to move its cell-based therapeutic implants into the clinic for phase 1 trials.
Displaying results 16-18 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top